Diabetes Mellitus, Type 2
"Diabetes Mellitus, Type 2" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY.
| Descriptor ID |
D003924
|
| MeSH Number(s) |
C18.452.394.750.149 C19.246.300
|
| Concept/Terms |
Diabetes Mellitus, Type 2- Diabetes Mellitus, Type 2
- Diabetes Mellitus, Noninsulin-Dependent
- Diabetes Mellitus, Ketosis-Resistant
- Diabetes Mellitus, Ketosis Resistant
- Ketosis-Resistant Diabetes Mellitus
- Diabetes Mellitus, Non Insulin Dependent
- Diabetes Mellitus, Non-Insulin-Dependent
- Non-Insulin-Dependent Diabetes Mellitus
- Diabetes Mellitus, Stable
- Stable Diabetes Mellitus
- Diabetes Mellitus, Type II
- NIDDM
- Diabetes Mellitus, Noninsulin Dependent
- Diabetes Mellitus, Maturity-Onset
- Diabetes Mellitus, Maturity Onset
- Maturity-Onset Diabetes Mellitus
- Maturity Onset Diabetes Mellitus
- MODY
- Diabetes Mellitus, Slow-Onset
- Diabetes Mellitus, Slow Onset
- Slow-Onset Diabetes Mellitus
- Type 2 Diabetes Mellitus
- Noninsulin-Dependent Diabetes Mellitus
- Noninsulin Dependent Diabetes Mellitus
- Maturity-Onset Diabetes
- Diabetes, Maturity-Onset
- Maturity Onset Diabetes
- Type 2 Diabetes
- Diabetes, Type 2
- Diabetes Mellitus, Adult-Onset
- Adult-Onset Diabetes Mellitus
- Diabetes Mellitus, Adult Onset
|
Below are MeSH descriptors whose meaning is more general than "Diabetes Mellitus, Type 2".
Below are MeSH descriptors whose meaning is more specific than "Diabetes Mellitus, Type 2".
This graph shows the total number of publications written about "Diabetes Mellitus, Type 2" by people in this website by year, and whether "Diabetes Mellitus, Type 2" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 18 | 3 | 21 |
| 1996 | 20 | 0 | 20 |
| 1997 | 15 | 3 | 18 |
| 1998 | 5 | 3 | 8 |
| 1999 | 5 | 0 | 5 |
| 2000 | 23 | 6 | 29 |
| 2001 | 11 | 4 | 15 |
| 2002 | 13 | 5 | 18 |
| 2003 | 4 | 2 | 6 |
| 2004 | 16 | 4 | 20 |
| 2005 | 21 | 2 | 23 |
| 2006 | 22 | 3 | 25 |
| 2007 | 10 | 5 | 15 |
| 2008 | 19 | 8 | 27 |
| 2009 | 15 | 7 | 22 |
| 2010 | 19 | 4 | 23 |
| 2011 | 29 | 7 | 36 |
| 2012 | 23 | 7 | 30 |
| 2013 | 25 | 4 | 29 |
| 2014 | 38 | 6 | 44 |
| 2015 | 24 | 3 | 27 |
| 2016 | 31 | 3 | 34 |
| 2017 | 21 | 5 | 26 |
| 2018 | 25 | 6 | 31 |
| 2019 | 37 | 3 | 40 |
| 2020 | 17 | 8 | 25 |
| 2021 | 27 | 5 | 32 |
| 2022 | 35 | 1 | 36 |
| 2023 | 32 | 0 | 32 |
| 2024 | 19 | 5 | 24 |
| 2025 | 6 | 3 | 9 |
To return to the timeline,
click here.
Below are the most recent publications written about "Diabetes Mellitus, Type 2" by people in Profiles.
-
GLP-1R/GCGR dual agonism dissipates hepatic steatosis to restore insulin sensitivity and rescue pancreatic ß-cell function in obese male mice. Nat Commun. 2025 May 21; 16(1):4714.
-
scPrediXcan integrates deep learning methods and single-cell data into a cell-type-specific transcriptome-wide association study framework. Cell Genom. 2025 May 14; 5(5):100875.
-
Geographic and Sociodemographic Factors and Receipt of Metabolic Disease Specialty Care. JAMA Netw Open. 2025 May 01; 8(5):e2511559.
-
GLP-1 RA and dual GIP/GLP-1 RA treatment in MODY: a descriptive case series. BMJ Open Diabetes Res Care. 2025 Apr 23; 13(2).
-
Metabolic dysfunction-associated steatotic liver disease in adults. Nat Rev Dis Primers. 2025 Mar 06; 11(1):14.
-
GLP-1RA Use and Thyroid Cancer Risk. JAMA Otolaryngol Head Neck Surg. 2025 Mar 01; 151(3):243-252.
-
Realigning diabetes regimens in older adults: a 4S Pathway to guide simplification and deprescribing strategies. Lancet Diabetes Endocrinol. 2025 05; 13(5):427-437.
-
Mitigating heart failure risk in patients with diabetes and chronic kidney disease. Curr Opin Cardiol. 2025 May 01; 40(3):178-183.
-
Deprescribing in Older Adults With Type 2 Diabetes: Associations With Patients' Perspectives: The Diabetes and Aging Study. J Am Geriatr Soc. 2025 Apr; 73(4):1155-1167.
-
Accelerated Longitudinal Glycemic Changes in Relation to Urinary Toxic/Essential Metals and Metal Mixtures Among Mexican Americans Living in Starr County, Texas. Diabetes Care. 2024 Nov 01; 47(11):1908-1915.